Richard Rychlik - Net Worth and Insider Trading

Richard Rychlik Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Richard Rychlik owns 1 companies in total, including Armata Pharmaceuticals Inc (ARMP) .

Click here to see the complete history of Richard Rychlik’s form 4 insider trades.

Insider Ownership Summary of Richard Rychlik

Ticker Comapny Transaction Date Type of Owner
ARMP Armata Pharmaceuticals Inc 2023-09-15 Corporate Controller and PFO

Richard Rychlik Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Richard Rychlik Ownership Network

Ownership Network List of Richard Rychlik

No Data

Ownership Network Relation of Richard Rychlik


Richard Rychlik Owned Company Details

What does Armata Pharmaceuticals Inc do?

Who are the key executives at Armata Pharmaceuticals Inc?

Richard Rychlik is the Corporate Controller and PFO of Armata Pharmaceuticals Inc. Other key executives at Armata Pharmaceuticals Inc include director & Chief Executive Officer Deborah Birx , Chief Financial Officer Julianne Averill , and Vice President,Finance & Admin Erin Butler .

Armata Pharmaceuticals Inc (ARMP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Armata Pharmaceuticals Inc (ARMP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Armata Pharmaceuticals Inc (ARMP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Armata Pharmaceuticals Inc (ARMP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Armata Pharmaceuticals Inc Insider Transactions

No Available Data

Richard Rychlik Mailing Address

Above is the net worth, insider trading, and ownership report for Richard Rychlik. You might contact Richard Rychlik via mailing address: 5005 Mcconnell Avenue, Los Angeles Ca 90066.

Discussions on Richard Rychlik

No discussions yet.